A recent study by Katherine Roland and colleagues from the CDC has found that a majority doctors are still recommending yearly Pap tests to screen for cervical cancer.
A recent study by Katherine Roland and colleagues from the CDC has found that a majority doctors are still recommending yearly Pap tests to screen for cervical cancer. The American College of Obstetricians and Gynecologists revised its guidelines in 2009 to the following:
• Women aged 21 to 30 should be screened every 2 years instead of annually, using either the standard Pap test or liquid-based cytology.
• Women aged 30 years and older who have had 3 consecutive negative cervical cytology test results may be screened once every 3 years with either the Pap test or liquid-based cytology.
• Women with certain risk factors may need more frequent screening, including those who have HIV, are immunosuppressed, were exposed to diethylstilbestrol (DES) in utero, and have been treated for cervical intraepithelial neoplasia (CIN) 2, CIN 3, or cervical cancer.
Why or why not? Share your thoughts in our comments section below.
Shift towards neoadjuvant chemotherapy found in ovarian cancer treatment
October 21st 2024A recent study shows a significant decrease in primary cytoreductive surgery utilization for advanced ovarian cancer, as neoadjuvant chemotherapy followed by interval cytoreductive surgery gains acceptance for its noninferior survival outcomes and reduced postoperative morbidity.
Read More
Family history criteria used to predict breast cancer genetic risk variants
September 26th 2024In a recent study, patients with a positive response to the Seven-Question Family History Questionnaire were more likely to present with a pathogenic or likely pathogenic variant in the BRCA1 and BRCA2 genes.
Read More
Offering cervical and colorectal cancer screening at breast cancer screening found effective
August 26th 2024In a recent study, women overdue for cervical cancer and colorectal cancer screening were more likely to receive coverage when offered during their breast cancer screening visit.
Read More